Cerus Corporation (NASDAQ:CERS) Just Reported And Analysts Have Been Cutting Their Estimates
NasdaqGM:CERS 1 Year Share Price vs Fair Value Explore Cerus's Fair Values from the Community and select yours...
| Ticker |
CERS
|
| CIK | 0001020214 |
| SIC | 3841 |
| Sector | Manufacturing |
| Industry Category | Medical Equipment |
| Industry Group | Surgical, Medical, And Dental Instruments And Supplies |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Cerus Corporation (NASDAQ:CERS) Just Reported And Analysts Have Been Cutting Their EstimatesNasdaqGM:CERS 1 Year Share Price vs Fair Value Explore Cerus's Fair Values from the Community and select yours... Cerus Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsNasdaqGM:CERS 1 Year Share Price vs Fair Value Explore Cerus's Fair Values from the Community and select yours Cerus... Cerus: Q2 Earnings SnapshotCERS) on Tuesday reported a loss of $5.7 million in its second quarter. On a per-share basis, the Concord, California-based company said it had a loss of 3 cents. The biomedical products company posted revenue of $52.4 million in the period. Cerus Corporation Announces Second Quarter 2025 Financial ResultsCONCORD, Calif., August 05, 2025--Cerus Corporation (Nasdaq:CERS) announced financial results for the second quarter ended June 30, 2025, and provided a business update. Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025CONCORD, Calif., July 22, 2025--Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2025 financial results will be released on Tuesday, August 5, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a general business overview and outlook. |